Objectives: To compare traditional risk factors for CVD (adiposity, dyslipidemia, hypertension), and novel early markers (arterial stiffness and myocardial structure), between youth with type 1 diabetes (T1D) and healthy controls.

Methods: We compared 100 youth with T1D (14-18 yrs) and 97 age- and sex-matched controls. BMI z-scores were computed and percent body fat (%BF) measured by DEXA. Age, sex and height-specific z-scores for blood pressure (BP) were calculated. HbA1c and lipids were measured fasted. Carotid-femoral pulse-wave velocity (Sphygmocor) estimated arterial stiffness. Cardiac magnetic resonance measured left ventricular diastolic myomass, papillary mass and average wall thickness. T-tests, Chi-square and Fisher’s exact determined differences between the groups.

Results: There were no differences in ethnicity, sex or pubertal stage across groups. Median T1D duration was 6.1 (IQR=3.3-10.5) yrs; average HbA1c was 8.5% (SD=1.5). Youth with T1D had higher adiposity, modestly higher triglycerides, LDL-c and diastolic BP (albeit in normal range), and increased myomass and average wall thickness, compared with controls (Table).

Conclusions: Early alterations in myocardial structure (by 14-18 yrs), along with adverse profiles in traditional risk factors suggest that CVD prevention should be initiated prior to adolescence in pediatric T1D.


S. Harnois-Leblanc: None. V. McNealis: None. M.G. Friedrich: Board Member; Self; Circle Cardiovascular Imaging Inc. A. Van Hulst: None. A. Nuyt: None. J. Bigras: None. T.A. Barnett: None. A. Benedetti: None. V. Drapeau: None. M. Henderson: None.


Canadian Society of Endocrinology and Metabolism/AstraZeneca; Fonds de recherche du Québec, Santé; Heart and Stroke Foundation of Canada (G-16-00012590); Canadian Institutes of Health Research (366194)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.